<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To compare intimal-medial thickness (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e>) and pulse wave conduction velocity (PWCV) in unstenosed arteries of the lower limb in subjects with and without type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and to determine the contribution of a range of <z:e sem="disease" ids="C0850624" disease_type="Disease or Syndrome" abbrv="">cardiovascular risk factors</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>RESEARCH DESIGN AND METHODS: <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e> and PWCV were determined in lower-limb arteries of 79 subjects with <z:mp ids='MP_0002055'>diabetes</z:mp> and 77 euglycemic subjects </plain></SENT>
<SENT sid="2" pm="."><plain>Plasma <z:chebi fb="23" ids="18059">lipids</z:chebi> were determined by enzymatic assays, and <z:chebi fb="15" ids="39026">LDL</z:chebi> particle size was measured by gradient gel electrophoresis </plain></SENT>
<SENT sid="3" pm="."><plain>Lag time for copper-induced oxidation of <z:chebi fb="15" ids="39026">LDL</z:chebi> was determined </plain></SENT>
<SENT sid="4" pm="."><plain><z:chebi fb="0" ids="22470">alpha-Tocopherol</z:chebi>, <z:chebi fb="1" ids="50211">retinol</z:chebi>, and <z:chebi fb="0" ids="22651">ascorbate</z:chebi> levels were determined by high-performance liquid chromatography, soluble E-selectin by enzyme-linked immunosorbent assay, and fibrinogen and factor VII by automated assays </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: Subjects with <z:mp ids='MP_0002055'>diabetes</z:mp> had greater superficial femoral artery (SFA) <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e>, popliteal artery (PA) <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e>, and SFA PWCV (<z:hpo ids='HP_0000001'>all</z:hpo> P &lt; 0.0001) </plain></SENT>
<SENT sid="6" pm="."><plain>In univariate analysis, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e> and PWCV correlated with increased waist-to-hip ratio, <z:chebi fb="4" ids="17855">triglycerides</z:chebi>, and fibrinogen and inversely with <z:chebi fb="4" ids="47775">HDL cholesterol</z:chebi> and <z:chebi fb="15" ids="39026">LDL</z:chebi> size </plain></SENT>
<SENT sid="7" pm="."><plain><z:chebi fb="0" ids="22651">Ascorbate</z:chebi> was inversely associated with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e>, and <z:chebi fb="15" ids="39026">LDL</z:chebi> lag time was inversely correlated with PWCV </plain></SENT>
<SENT sid="8" pm="."><plain>Subjects with the greatest number of features of the <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> had the highest <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e> and PWCV </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: Adverse changes in the structure and function of unstenosed lower-limb arteries are present in type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and are associated with features of the <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> </plain></SENT>
</text></document>